Thomson Reuters Corporation Peer Comparison
Metric | Value | Ranking | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $73.1 Billion | 2/13 | CTAS $76.6B |
TRI $73.1B |
CPRT $48.5B |
GPN $25.2B |
ARMK $8.7B |
MMS $5.6B |
CBZ $4.2B |
ABM $3.4B |
FA $2.5B |
AZZ $2.5B |
CASS $573.9M |
CVEO $364.4M |
PFMT $275.5M |
Gross Margin | 32% | 6/13 | CASS 100% |
GPN 62% |
CTAS 49% |
FA 49% |
CPRT 46% |
TRI 32% |
CBZ 24% |
MMS 22% |
AZZ 22% |
ABM 12% |
CVEO 11% |
ARMK 5% |
PFMT -14% |
Profit Margin | 26% | 2/13 | CPRT 34% |
TRI 26% |
CTAS 17% |
CBZ 16% |
GPN 13% |
CASS 9% |
MMS 6% |
AZZ 4% |
ABM 2% |
ARMK 1% |
FA -2% |
CVEO -3% |
PFMT -15% |
EBITDA margin | 43% | 1/13 | TRI 43% |
CPRT 43% |
GPN 38% |
CTAS 27% |
CBZ 22% |
AZZ 17% |
FA 17% |
MMS 12% |
CASS 12% |
CVEO 10% |
ARMK 6% |
ABM 5% |
PFMT -9% |
Quarterly Revenue | $1.9 Billion | 5/13 | ARMK $4.2B |
CTAS $2.5B |
GPN $2.4B |
ABM $2.0B |
TRI $1.9B |
MMS $1.3B |
CPRT $1.1B |
CBZ $494.3M |
AZZ $366.6M |
FA $169.4M |
CVEO $166.1M |
CASS $49.0M |
PFMT $27.3M |
Quarterly Earnings | $478.9 Million | 1/13 | TRI $478.9M |
CTAS $414.3M |
CPRT $382.3M |
GPN $313.3M |
MMS $80.5M |
CBZ $76.9M |
ARMK $53.4M |
ABM $43.8M |
AZZ $14.3M |
CASS $4.5M |
FA -$2.9M |
PFMT -$4.0M |
CVEO -$5.1M |
Quarterly Free Cash Flow | $285.7 Million | 3/13 | CTAS $591.1M |
CPRT $408.5M |
TRI $285.7M |
GPN $270.9M |
ARMK $133.9M |
ABM $101.5M |
MMS $87.2M |
AZZ $35.3M |
FA $31.9M |
CVEO $372,000 |
PFMT -$3.5M |
CBZ -$68.8M |
CASS -$0 |
Trailing 4 Quarters Revenue | $7.0 Billion | 5/13 | ARMK $18.3B |
GPN $9.8B |
CTAS $9.6B |
ABM $8.2B |
TRI $7.0B |
MMS $5.1B |
CPRT $4.2B |
CBZ $1.6B |
AZZ $1.5B |
FA $757.7M |
CVEO $699.3M |
CASS $198.6M |
PFMT $82.8M |
Trailing 4 Quarters Earnings | $2.4 Billion | 1/13 | ARMK $4.2B |
CTAS $2.5B |
GPN $2.4B |
ABM $2.0B |
TRI $1.9B |
MMS $1.3B |
CPRT $1.1B |
CBZ $494.3M |
AZZ $366.6M |
FA $169.4M |
CVEO $166.1M |
CASS $49.0M |
PFMT $27.3M |
Quarterly Earnings Growth | 187% | 2/13 | GPN 1424% |
TRI 187% |
MMS 153% |
AZZ 92% |
CTAS 20% |
CVEO 19% |
CPRT 9% |
CBZ 5% |
PFMT 5% |
ARMK -5% |
ABM -16% |
CASS -37% |
FA -251% |
Annual Earnings Growth | 355% | 1/13 | TRI 355% |
CBZ 222% |
CVEO 187% |
ARMK 125% |
GPN 81% |
AZZ 56% |
MMS 55% |
ABM 49% |
PFMT 28% |
CTAS 19% |
CPRT 13% |
CASS -4% |
FA -48% |
Quarterly Revenue Growth | 8% | 5/13 | MMS 12% |
CPRT 10% |
CBZ 9% |
AZZ 9% |
TRI 8% |
CTAS 8% |
GPN 6% |
PFMT 6% |
ABM 2% |
CASS 2% |
CVEO -1% |
FA -3% |
ARMK -9% |
Annual Revenue Growth | -1% | 10/13 | CBZ 22% |
CTAS 8% |
GPN 8% |
CPRT 7% |
CVEO 7% |
AZZ 6% |
ABM 3% |
MMS 3% |
CASS 2% |
TRI -1% |
ARMK -1% |
FA -7% |
PFMT -23% |
Cash On Hand | $1.9 Billion | 2/13 | GPN $2.2B |
TRI $1.9B |
CPRT $1.1B |
ARMK $414.1M |
CTAS $342.0M |
FA $245.4M |
CASS $223.7M |
MMS $118.3M |
ABM $60.7M |
CBZ $29.1M |
CVEO $16.8M |
AZZ $4.3M |
PFMT $3.8M |
Short Term Debt | $940.0 Million | 2/13 | GPN $2.7B |
TRI $940.0M |
CTAS $495.3M |
MMS $137.0M |
ARMK $92.5M |
ABM $59.8M |
CBZ $37.2M |
CPRT $20.5M |
CVEO $7.4M |
FA $3.4M |
PFMT $281,000 |
AZZ -$0 |
CASS -$0 |
Long Term Debt | $3.1 Billion | 3/13 | GPN $15.6B |
ARMK $5.9B |
TRI $3.1B |
CTAS $2.0B |
ABM $1.2B |
MMS $1.1B |
AZZ $970.6M |
FA $564.5M |
CBZ $436.3M |
CVEO $78.6M |
PFMT $5.0M |
CPRT $427,000 |
CASS $0 |
PE | 30.02 | 5/13 | FA 77.12 |
CTAS 48.73 |
CPRT 34.96 |
CBZ 33.58 |
TRI 30.02 |
AZZ 25.00 |
MMS 23.74 |
CASS 20.91 |
GPN 19.23 |
ARMK 13.90 |
ABM 13.74 |
CVEO 9.89 |
PFMT -1.00 |
PS | 10.47 | 2/13 | CPRT 11.65 |
TRI 10.47 |
CTAS 7.98 |
PFMT 3.33 |
FA 3.30 |
CASS 2.89 |
GPN 2.58 |
CBZ 2.57 |
AZZ 1.59 |
MMS 1.09 |
CVEO 0.52 |
ARMK 0.48 |
ABM 0.42 |
PB | 6.63 | 3/13 | CTAS 17.74 |
CPRT 6.74 |
TRI 6.63 |
PFMT 3.55 |
MMS 3.11 |
ARMK 3.00 |
FA 2.76 |
AZZ 2.62 |
CBZ 2.60 |
CASS 2.50 |
ABM 1.86 |
CVEO 1.21 |
GPN 1.10 |
PC | 38.51 | 8/13 | AZZ 563.42 |
CTAS 223.93 |
CBZ 143.67 |
PFMT 72.73 |
ABM 56.47 |
MMS 47.08 |
CPRT 44.52 |
TRI 38.51 |
CVEO 21.75 |
ARMK 21.01 |
GPN 11.63 |
FA 10.20 |
CASS 2.56 |
Liabilities to Equity | 0.71 | 10/13 | CASS 8.93 |
ARMK 3.34 |
ABM 1.67 |
AZZ 1.35 |
GPN 1.30 |
MMS 1.26 |
CTAS 1.12 |
FA 0.80 |
CVEO 0.72 |
TRI 0.71 |
CBZ 0.67 |
PFMT 0.28 |
CPRT 0.11 |
ROA | 0.13 | 3/13 | CPRT 17% | CTAS 17% | TRI 13% | CVEO 7% | MMS 6% | CBZ 6% | ARMK 5% | ABM 5% | AZZ 4% | GPN 3% | FA 2% | CASS 1% | PFMT -6% |
ROE | 0.22 | 2/13 | CTAS 36% |
TRI 22% |
ARMK 22% |
CPRT 19% |
ABM 14% |
CBZ 14% |
MMS 13% |
CVEO 12% |
CASS 12% |
AZZ 10% |
GPN 6% |
FA 4% |
PFMT -8% |
Current Ratio | 2.42 | 4/13 | CPRT 9.84 |
PFMT 4.60 |
CBZ 3.76 |
TRI 2.42 |
CVEO 2.41 |
FA 2.25 |
CTAS 1.89 |
GPN 1.80 |
MMS 1.79 |
AZZ 1.74 |
ABM 1.60 |
ARMK 1.30 |
CASS 1.11 |
Quick Ratio | 0.24 | 3/13 | FA 77.12 |
CTAS 48.73 |
CPRT 34.96 |
CBZ 33.58 |
TRI 30.02 |
AZZ 25.00 |
MMS 23.74 |
CASS 20.91 |
GPN 19.23 |
ARMK 13.90 |
ABM 13.74 |
CVEO 9.89 |
PFMT -1.00 |
Long Term Debt to Equity | 0.28 | 9/13 | ARMK} 2.03 |
AZZ} 1.04 |
GPN} 0.70 |
ABM} 0.67 |
MMS} 0.63 |
FA} 0.62 |
CBZ} 0.50 |
CTAS} 0.47 |
TRI} 0.28 |
CVEO} 0.26 |
PFMT} 0.06 |
CPRT} 0.00 |
CASS} 0.00 |
Debt to Equity | 0.35 | 9/13 | ARMK 2.15 |
AZZ 1.04 |
GPN 0.82 |
MMS 0.77 |
ABM 0.76 |
FA 0.63 |
CTAS 0.62 |
CBZ 0.50 |
TRI 0.35 |
CVEO 0.30 |
PFMT 0.07 |
CPRT 0.02 |
CASS 0.00 |
Burn Rate | -16.02 | 11/13 | FA 9.32 |
ABM 2.93 |
GPN 2.22 |
ARMK 2.02 |
CVEO 1.65 |
PFMT 0.88 |
AZZ 0.18 |
CBZ -0.58 |
CTAS -1.63 |
CPRT -2.89 |
TRI -16.02 |
CASS -49.89 |
MMS -83.94 |
Cash to Cap | 0.03 | 6/13 | CASS 0.39 |
FA 0.10 |
GPN 0.09 |
ARMK 0.05 |
CVEO 0.05 |
TRI 0.03 |
CPRT 0.02 |
ABM 0.02 |
MMS 0.02 |
CBZ 0.01 |
PFMT 0.01 |
CTAS 0.00 |
AZZ 0.00 |
CCR | 0.60 | 9/13 | ARMK 2.50 |
AZZ 2.48 |
ABM 2.32 |
CTAS 1.43 |
MMS 1.08 |
CPRT 1.07 |
PFMT 0.88 |
GPN 0.86 |
TRI 0.60 |
CVEO -0.07 |
CBZ -0.90 |
FA -10.96 |
CASS |
EV to EBITDA | 93.77 | 4/13 | CTAS} 119.11 |
CPRT} 97.45 |
FA} 97.12 |
TRI} 93.77 |
CASS} 60.40 |
AZZ} 54.52 |
ARMK} 53.37 |
GPN} 45.19 |
ABM} 44.43 |
MMS} 43.31 |
CBZ} 42.31 |
CVEO} 25.58 |
PFMT} -114.91 |
EV to Revenue | 10.75 | 2/13 | CPRT 11.42 |
TRI 10.75 |
CTAS 8.22 |
GPN 4.22 |
FA 3.73 |
PFMT 3.35 |
CBZ 2.82 |
AZZ 2.22 |
CASS 1.76 |
MMS 1.33 |
ARMK 0.79 |
CVEO 0.62 |
ABM 0.58 |